Inflammation in the central nervous system in multiple sclerosis: The role of chemokines and their receptors

Author： Simpson Julie E.   Woodroofe M. Nicola  

Publisher： VSP

ISSN： 1568-5608

Source： Inflammopharmacology, Vol.9, Iss.1-2, 2001-05, pp. : 23-33

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chemokines and Their Receptors in Central Nervous System Disease

By  

Current Drug Targets, Vol. 7, Iss. 1, 2006-01 ,pp. : 29-46

Bentham Science Publishers

Access to resources Recommend Favorite

Comment and reply on:Emerging role of Th22 and IL-22 in multiple sclerosis, an autoimmune disease in the central nervous system

By Zhou Chunkui   Zhang Beilin   Yang Yi   Zhang Hongliang  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 11, 2013-11 ,pp. : 1381-1382

Informa Healthcare

Access to resources Recommend Favorite

A 2 Adenosine Receptors: Their Presence and Neuromodulatory Role in the Central Nervous System

By Latini S.   Pazzagli M.   Pepeu G.   Pedata F.  

General Pharmacology, Vol. 27, Iss. 6, 1996-09 ,pp. : 925-933

Elsevier

Access to resources Recommend Favorite

Chemokines and Chemokine Receptors: Potential Therapeutic Targets in Multiple Sclerosis

By  

Current Drug Targets. Inflammation & Allergy, Vol. 3, Iss. 3, 2004-01 ,pp. : 279-290

Bentham Science Publishers

Access to resources Recommend Favorite

From Cannabis to Endocannabinoids in Multiple Sclerosis: A Paradigm of Central Nervous System Autoimmune Diseases

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 4, Iss. 6, 2005-12 ,pp. : 667-675

Bentham Science Publishers

Access to resources Recommend Favorite